NMRA: Neumora Therapeutics, Inc. Stock

by  •  • Comments Off on NMRA: Neumora Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 331.20
Enterprise Value ($M) 55.49
Book Value ($M) 320.74
Book Value / Share 1.99
Price / Book 1.03
NCAV ($M) 316.81
NCAV / Share 1.96
Price / NCAV 1.05

Profitability (mra)
Return on Invested Capital (ROIC) -0.91
Return on Assets (ROA) -0.59
Return on Equity (ROE) -0.63

Liquidity (mrq)
Quick Ratio 10.98
Current Ratio 10.98

Balance Sheet (mrq) ($M)
Current Assets 348.61
Assets 352.54
Liabilities 31.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-22 13D/A ARCH Venture Fund XII, L.P. 19.80 0.04
11-12 13G Softbank Group Corp 4.70 -1.31
02-14 13G Berns Paul L 5.20

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-07 10-K Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-21 496,481 2,934,311 16.92
2025-01-17 1,106,792 4,062,672 27.24
2025-01-16 591,948 1,942,014 30.48

(click for more detail)

Similar Companies
NBIX – Neurocrine Biosciences, Inc. NEOG – Neogen Corporation
NKTX – Nkarta, Inc. NUVL – Nuvalent, Inc.
NVAX – Novavax, Inc.


Financial data and stock pages provided by
Fintel.io